USX:GRCL - Gracell Biotechnologies Inc Gracell Biotechnologies Inc.
Sector: Health Care, Industry: Biotechnology
Next Earnings: 13 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance Note: This stock seems to be inactive

USD 0    -10.25 (-100%)

4 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Wei Cao BM, Ph.D.

IPO: 2021-01-08

Headquarters: US

Employees: 314

Homepage

Description

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms